Longeveron Inc. Common Stock

LGVNNASDAQ • USD
ThemeLongevity & Aging›Age-Related Therapeutics
2.58 USD
↗ 0.00 (0.00%)AT CLOSE (03:59 PM EDT)
2.57
↘ 0.02 (0.58%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
2.57
↘ 0.02 (0.58%)
🔴Market: CLOSED

LGVN is currently priced at $2.58. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, LGVN appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 2, 2026.

Open?$2.56
High?$2.68
Low?$2.54
Prev. Close?$2.58
Volume?20.8K
Avg. Volume?267.9K
VWAP?$2.61
Rel. Volume?0.08x
Bid / Ask
Bid?$2.52 × 100
Ask?$2.73 × 100
Spread?$0.21
Midpoint?$2.63
Valuation & Ratios
Market Cap?8.2M
Shares Out?3.0M
Float?27.7M
Float %?92.0%
P/E Ratio?N/A
P/B Ratio?0.79
EPS?-$7.36
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Themes
Longevity & Aging›Age-Related TherapeuticsHealthcare - Genomics & Precision Medicine›Gene Therapy & Gene Editing
Employees
38
Market Cap
8.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.longeveron.com
Listed
2021-02-12
Address
1951 NW 7TH AVENUE
MIAMI, FL 33136
Phone: 305-302-7158
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
35
Short Sent.?
83
Piotroski F-Score?2/9Weak
Altman Z-Score?-16.45Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?0.77%Low
Short Interest?213.8K
Days to Cover?4.7
Free Float27.7M
Avg Daily Volume45.9K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.23Strong
Quick Ratio?2.23Strong
Cash Ratio?1.98Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.79CHEAP▾
P/S?
Peers
100
S&P
17
6.93FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.1CHEAP▾
EV/Sales?
S&P
97
-1.56CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-225.7%WEAK▾
ROA?
S&P
3
-151.6%WEAK▾
Cash Flow & Enterprise
FCF?$-20534000
Enterprise Value?$-1851449
Fundamentals ratios updated end of day
MarketsMoversWatchlist